Subscribe on Apple ► [ Ссылка ]
Listen on Google ► [ Ссылка ]
Subscribe on Spotify ► [ Ссылка ]
IG Trading the Markets: [ Ссылка ]

With recent highs on global equity indices, IGTV’s Jeremy Naylor asked Dr Navid Malik, Head of Life Sciences Research at The Life Sciences Division, whether investors and traders are getting ahead of themselves in pricing risk. Dr Malik, as well as being a medical doctor and an expert in COVID-19, is also an investor and runs the research desk at The Life Sciences Division.

In this episode, the discussion begins with the recent developments on how the virus seems to be mutating and then moves onto the ways in which pharma and biotech companies are rising to the challenge.

Learn more about IG: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
LinkedIn: [ Ссылка ]

We provide fast and flexible access to over 17,000 financial markets – including indices, shares, forex and commodities – through our award-winning range of platforms and apps.

Established in 1974 as the world’s first financial spread betting firm, we’re now the world’s No.1 provider of CFDs and spread betting* and a global leader in forex. We also offer an execution-only share dealing service in the UK, Ireland, Germany, Austria and the Netherlands. Our range of affordable, fully managed investment portfolios rounds out our comprehensive offering to investors and active traders.

Through our low fees and smart price-sourcing technology, we help traders keep their costs down.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider†. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money. Professional clients can lose more than they deposit.

* Based on revenue excluding FX (published financial statements, February 2018).

† For the 12 months preceding 1 April 2020.

свернуть